NanJing Pharmaceutical Company Limited (SHA:600713)

SHA:600713 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,623	6,494	6,342	6,709	5,114	4,635
Market Cap Growth	19.87%	2.41%	-5.47%	31.18%	10.34%	-4.92%
Enterprise Value	17,895	17,415	18,818	16,766	14,628	11,389
Last Close Price	5.06	4.80	4.51	4.65	4.35	3.86
PE Ratio	12.67	11.38	10.98	11.26	10.12	12.31
Forward PE	-	27.42	27.42	27.42	27.42	27.42
PS Ratio	0.12	0.12	0.12	0.13	0.11	0.12
PB Ratio	0.84	0.83	0.87	1.00	0.98	0.96
P/TBV Ratio	1.01	0.99	1.03	1.18	1.20	1.19
P/FCF Ratio	47.29	4.08	3.63	-	13.15	-
P/OCF Ratio	14.49	3.04	3.33	-	7.36	-
EV/Sales Ratio	0.33	0.32	0.35	0.33	0.32	0.29
EV/EBITDA Ratio	10.51	10.41	11.38	10.87	10.10	9.79
EV/EBIT Ratio	12.30	11.33	12.55	12.07	11.25	11.09
EV/FCF Ratio	127.78	10.95	10.76	-	37.63	-
Debt / Equity Ratio	1.61	1.31	1.26	1.83	1.89	1.80
Debt / EBITDA Ratio	7.44	5.70	5.15	7.41	6.40	7.46
Debt / FCF Ratio	90.44	6.41	5.21	-	25.38	-
Asset Turnover	1.68	1.82	1.79	1.75	1.83	1.76
Inventory Turnover	8.47	8.33	8.68	9.12	9.83	9.58
Quick Ratio	1.06	1.16	1.00	0.97	0.99	0.92
Current Ratio	1.46	1.63	1.40	1.31	1.34	1.23
Return on Equity (ROE)	9.52%	9.88%	10.22%	12.00%	12.15%	10.06%
Return on Assets (ROA)	2.80%	3.25%	3.12%	3.02%	3.30%	2.83%
Return on Capital (ROIC)	4.51%	5.59%	5.32%	5.10%	5.69%	4.93%
Return on Capital Employed (ROCE)	11.60%	11.30%	15.20%	14.80%	15.60%	16.60%
Earnings Yield	8.31%	8.79%	9.11%	8.88%	9.88%	8.12%
FCF Yield	2.11%	24.50%	27.57%	-12.48%	7.60%	-30.19%
Dividend Yield	3.37%	3.54%	3.55%	3.01%	2.76%	2.85%
Payout Ratio	85.44%	88.47%	101.75%	81.07%	185.06%	93.72%
Buyback Yield / Dilution	-6.39%	-0.33%	-3.54%	-20.39%	0.10%	-0.09%
Total Shareholder Return	-3.02%	3.21%	0.00%	-17.39%	2.86%	2.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.